-transparent.png){kind=logo}
Serum gamma-GT activity was significantly (0.01 greater than P greater than 0.001) elevated in 18 out of 30 epileptics receiving carbamazepine (CBZ), i.e. in 60%. The incidence of abnormal gamma-GT levels in the control group (25 neurotic patients taking minor tranquilizers) was lower (12%). The possible relationships between the enzyme induction or chronic hepatic toxicity and the elevation of serum gamma-GT activity in epileptics taking CBZ are discussed.
Related Publications
G Mapelli, and
M Pavoni, and
B Currò Dossi, and
R Huber
August 1987,
Xenobiotica; the fate of foreign compounds in biological systems,
G Mapelli, and
M Pavoni, and
B Currò Dossi, and
R Huber
January 1996,
European journal of clinical pharmacology,
G Mapelli, and
M Pavoni, and
B Currò Dossi, and
R Huber
June 1996,
Mutation research,
G Mapelli, and
M Pavoni, and
B Currò Dossi, and
R Huber
June 1979,
Biochemical pharmacology,
G Mapelli, and
M Pavoni, and
B Currò Dossi, and
R Huber
January 1970,
Advances in enzyme regulation,
G Mapelli, and
M Pavoni, and
B Currò Dossi, and
R Huber
October 1971,
Nederlands tijdschrift voor geneeskunde,
G Mapelli, and
M Pavoni, and
B Currò Dossi, and
R Huber
September 1984,
Ginecologia y obstetricia de Mexico,
G Mapelli, and
M Pavoni, and
B Currò Dossi, and
R Huber
January 1974,
Acta biologica et medica Germanica,
G Mapelli, and
M Pavoni, and
B Currò Dossi, and
R Huber
January 1967,
Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie,
G Mapelli, and
M Pavoni, and
B Currò Dossi, and
R Huber
September 1975,
Biulleten' eksperimental'noi biologii i meditsiny,
